ReviewCureus2025

Cardiorenal Safety Markers With Injectable Glucagon-Like Peptide-1 (GLP-1) Agonists in Type 2 Diabetes: A Network Meta-Analysis.

Abigail Rai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.